Invention Grant
- Patent Title: Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)
-
Application No.: US16636250Application Date: 2018-08-08
-
Publication No.: US12091463B2Publication Date: 2024-09-17
- Inventor: Nikolai Kley , Jan Tavernier , Lennart Zabeau , Erik Depla
- Applicant: Orionis Biosciences Inc. , Orionis Biosciences BV
- Applicant Address: US MA Newton
- Assignee: Orionis Biosciences, Inc.,Orionis Biosciences BV
- Current Assignee: Orionis Biosciences, Inc.,Orionis Biosciences BV
- Current Assignee Address: US MA Newton; BE Ghent
- Agency: Morgan, Lewis & Bockius LLP
- International Application: PCT/US2018/045742 2018.08.08
- International Announcement: WO2019/032662A 2019.02.14
- Date entered country: 2020-10-16
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K38/17 ; A61K38/21 ; A61K39/395 ; A61K39/40 ; A61K39/42 ; A61P25/00 ; C07K14/47 ; C07K16/00 ; C07K16/28
Abstract:
The present invention relates, in part, to agents that bind Clec9A and their use as diagnostic and therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the Clec9A binding agents and their use in the treatment of various diseases.
Public/Granted literature
- US20210024637A1 CLEC9A BINDING AGENTS AND USE THEREOF Public/Granted day:2021-01-28
Information query
